ARCHIVE ISSUES
June 2023
Articles include:
Price of Precision: Patients, Oncologists Highlight Costs of Fighting for Access to Newest Drugs, Precision Oncology Marches on Amid Manufacturing Woes, Regulatory Debates, Guideline Limitations
Read More
March 2023
Articles include:
Drugmakers Still Betting on Anti-Amyloid Approach in Alzheimer’s Amid Skepticism, Less-Buzzy JP Morgan Still Provides Insights Into Companies’ Precision Medicine Plans
Read More
December 2022
Articles include:
Measurable Residual Disease Detection in Hematological Malignancies: A Review from Research Tool to Clinical Diagnostic, Spatialomics delivered to the clinic for improved health outcomes in Barrett’s esophagus
Read More
September 2022
Articles include:
Why Equitable Access Depends on Comprehensive Genomic Profiling, Clinical Implications and Utility of Polygenic Risk Scores in Women at Elevated Risk for Breast Cancer, Genomic Innovation Democratizes Precision Medicine
Read More
June 2022
Articles include:
The Center for Applied Genomics at The Children’s Hospital of Philadelphia: Perspectives on a Decade with the Electronic Medical Records and Genomics (eMERGE) Consortium, Clinical trials for the management of malignant lymphoma and leukemia.
Read More
March 2022
Articles include:
Applications of Spatial‑Omics in Clinical Translational Cancer Research, Illumina‑SomaLogic Deal to bring together genomics and proteomics technology platforms, How I Learned the Hard Way to Ask Questions About Medications.
Read More
December 2021
Articles include:
The impacts of biomarkers on precision, Pfizer’s Precision Medicine Pipeline and Technology Portfolio, Legal and Liability Implications of Pharmacogenomics for Physicians and Pharmacists.
Read More
September 2021
Articles include:
The Integration of Personalized Medicine into Healthcare: Advancing the Promise to More Patients, The value of adding RNA sequencing to precision biomarker strategy, As Targeted Therapies Expand Beyond Cancer, Companion Diagnostics Must Improve.
Read More
June 2021
Articles include:
myRabble: A novel patient platform to improve access to personalized medicine, Clinical data and precision medicine: The urgent need for in‑house NGS capabilities at community hospitals.
Read More
March 2021
Articles include:
Integrating biomarker and translational research in a drug development pipeline, Early Detection of Cancer: Transitioning from Emerging to Established Companies and Technologies.
Read More
December 2020
Articles include:
Letter to the Journal: The COVID-19 innovation race, a case study
Personalised Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!
Read More
September 2020
Articles include:
Cell and gene therapy: OVERVIEW, CURRENT LANDSCAPE AND FUTURE TRENDS
Pioneering precision medicine in rheumatoid arthritis
Read More
June 2020
Articles include:
Using tears for precision diagnostics and the development of a potential new therapy for age- related macular degeneration
The dal-GenE trial: A case study of precision medicine in the cardiovascular setting
Read More
March 2020
Articles include:
Personalized Medicine in the Aftermath of COVID-19
Quick takes: Q&A with Jeff Evelhoch on Imaging Biomarkers for Alzheimer’s Disease
Read More
December 2019
Articles include:
A Case Study of Europe and Beyond
Fighting for Their Lives – The Battle of the BPAN Warriors
Read More
September 2019
Articles include:
Shadow of the Future: Precision Medicine in Multiple Myeloma
Precision prescribing with pharmacogenomics
Read More
June 2019
Articles include:
Expanding Precision Medicine
Rethinking patient education in oncology in the age of precision medicine
Read More
March 2019
Articles include:
Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Read More
